mHealth Skill Enhancement Plus Phone CBT for Type 2 Diabetes Distress Medication Nonadherence: Pilot Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 13
- 试验地点
- 2
- 主要终点
- HbA1c Level Change Scores From Baseline to 16 Weeks
研究概览
简要总结
This is a pilot study examining the clinical effects of a brief Cognitive Therapy phone approach augmented with a CBT smartphone app geared towards patients with type 2 diabetes patients in poor control.
详细描述
A significant problem in primary care healthcare delivery is the lack of interventions to improve medication and overall regimen adherence in persons with Type 2 diabetes (T2DM). Diabetes distress, a negative response to the diagnosis of T2DM, danger of complications, and self-management burdens is present in up to 70% of persons with T2DM. Distress is a significant factor in medication nonadherence and poor glycemic control. Treatment adherence is vital to maintain glucose control and reduce complications.
The literature has identified dysfunctional thinking patterns such as beliefs (e.g., I can't handle taking these medications), assumptions (e.g., I know I will have side effects to these medications) and interpretations (e.g., I'm too overwhelmed to do all of this stuff) as critical variables that impact both distress and T2DM treatment adherence. Current treatment strategies within primary care do not address the dysfunctional thinking patterns that affect the patient's distress level, T2DM medication adherence, and complex daily self-care activities.
Cognitive behavior therapy (CBT), a well-established evidenced-based treatment, helps patients to identify, and restructure dysfunctional thinking patterns. The investigators propose to test a brief phone CBT approach that is supported by a comprehensive mobile phone CBT skills practice application (app) within primary care. The promising results of the investigators preliminary studies using a mobile phone app to stimulate real-time CBT skills practice prompt us to propose a pilot of its use with patients with T2DM with the following aims:
Primary aim: examine feasibility and acceptability of the assessment protocol, and the recruitment, and retention of study participants.
Secondary aim: 1) collect preliminary data on the effect of the intervention on clinical outcomes, e.g., self-reported adherence to medication and self-management adherence, e.g., diet, exercise; levels of diabetes distress, diabetes medication beliefs, and distal T2DM outcomes (HbA1c level and body mass index).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 30 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •have a diagnosis of T2DM;
- •have a score of >3 on the Diabetes Distress Scale;
- •be taking at least one oral antihyperglycemic agent (the patient may also be using injectable antihyperglycemic medications, including insulin);
- •have an HbA1c level of greater than 8 at baseline;
- •be receiving treatment for T2DM in the primary care setting;
- •be aged 30 - 65 years and
- •be able to read at the 8th-grade level and to provide informed consent. -
排除标准
- •diagnosis of bipolar disorder or schizophrenia; primary diagnosis of obsessive-compulsive disorder, posttraumatic stress disorder, substance abuse, or dependence in the last 6 months; or any psychotic disorder;
- •diabetes treated without oral medications;
- •inability to read or comprehend English at the 8th-grade level;
- •refusal to provide informed consent;
- •dementia or disorders with substantial cognitive impairment; and
- •serious suicidal risk -
结局指标
主要结局
HbA1c Level Change Scores From Baseline to 16 Weeks
时间窗: baseline to 16 weeks
Change from baseline HbA1c level to post intervention
Computer System Usability Questionnaire (CSUQ)
时间窗: 16 weeks
The CSUQ measures feasibility and acceptability of the phone application. Adapted from Lewis JR.: IBM Computer Usability Satisfaction Questionnaires: Psychometric Evaluation and Instructions for Use. International Journal of Human-Computer Interaction 1995; 7 (1):67-78. Scale is scored as a mean value, range is from 1 to 7. In this adaptation lower scores are better usability.
次要结局
- Body Mass Index Change(baseline to 16 weeks)
- MEMS (Medication Electronic Monitoring System) Cap Electronic Pill Bottle Adherence(16 weeks)
- Diabetes Distress Scale- Change Score(baseline to 16 weeks)
研究者
Judith A. Callan PhD. RN
Research Assistant Professor
University of Pittsburgh